Dr. Michael Meaney, Depression Task Force Scientist, Elected to National Academy of Medicine,
October 22, 2025
Dr. Michael Meaney, PhD, a member of HDRF’s Depression Task Force, has recently been elected as an International Member of the National Academy of Medicine (NAM), one of the highest honors in health and science. Only 10 international members are elected each year across all fields of biosciences, medicine, public health, and policy.
Dr. Meaney is a James McGill Professor of Medicine in the Departments of Psychiatry and Neurology & Neurosurgery at McGill University. He was honored by NAM “for his exception research that is often credited with launching the field of behavioral epigenetics by demonstrating how early life adversity results in epigenetic modifications of key stress-responsive genes, thereby producing risk for altered brain development and the emergence of psychopathology.”
Dr. Meaney is one of nine senior investigators who make up HDRF’s Depression Task Force. The Depression Task Force is a consortium of some of the world’s top neuorscientists working together to study how depression pathways develop with the goal of developing more effective treatments for the disorder. Only a collaborative effort involving many scientists across many different labs can take on such a monumental mission.
To support the work of Dr. Meaney and our Depression Task Force, donate to HDRF today. Every dollar raised directly supports our scientists. Their ground-breaking research brings us closer every day to a future without depression.